Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Beaumont

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Clinical Pharmacokinetics|February 20, 2016
Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium ChannelsHannah M Jones, Richard P Butt, Rob W Webster, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related PainMark D Andrews, Kerry Af Forselles, Kevin Beaumont, et al.
Journal of Medicinal Chemistry|November 10, 2007
Discovery of potent & selective inhibitors of activated thrombin-activatable fibrinolysis inhibitor for the treatment of thrombosisMark E Bunnage, Julian Blagg, John Steele, et al.
Bioorganic & Medicinal Chemistry|October 31, 2006
Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorderDavid C Pryde, Andrew S Cook, Denise J Burring, et al.
Frontiers in Medicine|August 15, 2022
Human Recombinant Alkaline Phosphatase (Ilofotase Alfa) Protects Against Kidney Ischemia-Reperfusion Injury in Mice and Rats Through Adenosine ReceptorsDiane L Rosin, J Perry Hall, Shuqiu Zheng, et al.
Journal of Medicinal Chemistry|July 11, 2006
Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Synthesis and activity of functionalized glutaramidesDavid C Pryde, Graham N Maw, Simon Planken, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2014
Inhibition of TRPM8 channels reduces pain in the cold pressor test in humansWendy J Winchester, Katrina Gore, Sophie Glatt, et al.
Regulatory Toxicology and Pharmacology : RTP|April 19, 2021
An orthogonal methods assessment of topical drug concentrations in skin and the impact for risk assessment in the viable epidermisBrett D Hollingshead, Lindsay Tomlinson, Jim Finley, et al.
Bioorganic & Medicinal Chemistry|November 22, 2011
The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokineticsDavid J Rawson, Stephen Ballard, Christopher Barber, et al.
Journal of Medicinal Chemistry|April 10, 2018
Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac FibrosisElnaz Menhaji-Klotz, Kevin D Hesp, Allyn T Londregan, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical Pharmacokinetics|February 20, 2016
Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium ChannelsHannah M Jones, Richard P Butt, Rob W Webster, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related PainMark D Andrews, Kerry Af Forselles, Kevin Beaumont, et al.
Journal of Medicinal Chemistry|November 10, 2007
Discovery of potent & selective inhibitors of activated thrombin-activatable fibrinolysis inhibitor for the treatment of thrombosisMark E Bunnage, Julian Blagg, John Steele, et al.
Bioorganic & Medicinal Chemistry|October 31, 2006
Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorderDavid C Pryde, Andrew S Cook, Denise J Burring, et al.
Frontiers in Medicine|August 15, 2022
Human Recombinant Alkaline Phosphatase (Ilofotase Alfa) Protects Against Kidney Ischemia-Reperfusion Injury in Mice and Rats Through Adenosine ReceptorsDiane L Rosin, J Perry Hall, Shuqiu Zheng, et al.
Journal of Medicinal Chemistry|July 11, 2006
Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Synthesis and activity of functionalized glutaramidesDavid C Pryde, Graham N Maw, Simon Planken, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2014
Inhibition of TRPM8 channels reduces pain in the cold pressor test in humansWendy J Winchester, Katrina Gore, Sophie Glatt, et al.
Regulatory Toxicology and Pharmacology : RTP|April 19, 2021
An orthogonal methods assessment of topical drug concentrations in skin and the impact for risk assessment in the viable epidermisBrett D Hollingshead, Lindsay Tomlinson, Jim Finley, et al.
Bioorganic & Medicinal Chemistry|November 22, 2011
The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokineticsDavid J Rawson, Stephen Ballard, Christopher Barber, et al.
Journal of Medicinal Chemistry|April 10, 2018
Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac FibrosisElnaz Menhaji-Klotz, Kevin D Hesp, Allyn T Londregan, et al.
Pageof 5